Navigation Links
Boulder Diagnostics Licenses Novel Rapid Detection Technology for Homocysteine and Related Compounds from Portland State University
Date:1/20/2012

BOULDER, Colo. and PORTLAND, Ore., Jan. 20, 2012 /PRNewswire/ -- Boulder Diagnostics Inc. and Portland State University (PSU) announced today the entry into a license and collaboration agreement to develop rapid diagnostic tests for homocysteine and related compounds based on a highly specific dye technology developed at PSU. Under the agreement Boulder will finance further research at the Department of Chemistry, and PSU will be entitled to royalties on future sales of the licensed technology. Further details were not disclosed.

The innovative and highly specific dye technology developed in the laboratory of Prof. Robert Strongin at PSU enables the development of rapid diagnostic tests for homocysteine and related compounds. The new dye technology will be used in medical tests to help determine indicators for a variety of diseases, including cancer, Alzheimer's, Parkinson's, cystic fibrosis, and HIV.

"The groundbreaking technology of Prof. Strongin and his team can form the basis for a new line of products," says Wolfgang Pieken, CEO of Boulder Diagnostics Inc.

"We are excited to adapt our innovative detection chemistry to rapid diagnostic tests with Boulder Diagnostics," comments Robert Strongin, Professor of Chemistry at Portland State University.

Editor's note

For further information, please contact:

Boulder Diagnostics: Wolfgang Pieken, CEO
6395 Gunpark Drive, Ste W - Boulder, CO 80301
Phone: 720.897.6276 - info@boulderdiagnostics.com
http://www.boulderdiagnostics.com

Portland State University: Joseph Janda, Director of Innovation & Intellectual Property
PO Box 751 - Portland, OR 97207-0751
Phone: 503.725.8454 - iia@pdx.edu
http://www.pdx.edu

About Boulder Diagnostics

Boulder Diagnostics Inc. provides new diagnostic solutions to undeserved or underperforming disease diagnostics areas. It currently markets novel specific antibody reagents for the diagnosis of parasite infections.

About Portland State University (PSU)

Located in Portland, Oregon, PSU has about 30,000 undergraduate and graduate students. PSU's motto is "Let Knowledge Serve the City," and it provides every student with opportunities to work with businesses, schools and organizations on real-world projects. Its downtown campus exhibits PSU's commitment to sustainability through green buildings and business practice. Sustainability is incorporated into much of PSU's curriculum.

This press release was issued through eReleases(R).  For more information, visit eReleases Press Release Distribution at http://www.ereleases.com.


'/>"/>
SOURCE Boulder Diagnostics Inc.; Portland State University
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. CU-Boulder python study may have implications for human heart health
2. Novel CU-Boulder technique shrinks size of nanotechnology circuitry
3. Ultrafast lasers give CU-Boulder researchers a snapshot of electrons in action
4. India In Vitro Diagnostics Market Outlook to 2017- Clinical Chemistry Genetic Testing, Haematology, Histology and Cytology, Immuno Chemistry, Infectious Immunology and Microbiology Culture
5. QIAGEN Gains Rights to Genomic Biomarkers for Lung, Brain and Other Cancers to Expand its Pipeline of Companion Diagnostics
6. Exagen Diagnostics Launches Cutting-Edge Lupus Diagnostic
7. SuperNova Diagnostics® to Present at Biotech Showcase™ 2012 During JP Morgan Healthcare Conference January 9 - 12
8. S.E.D. Labs to be Acquired by Quest Diagnostics
9. Acumen Pharmaceuticals Regains Worldwide Rights to Anti-ADDL Antibody Therapeutics and Diagnostics for Alzheimers Disease From Merck
10. SuperNova Diagnostics® to Present at the 23rd Annual Piper Jaffray Healthcare Conference in New York City
11. Quest Diagnostics CE Marks Simplexa™ Test for Cytomegalovirus for Sale in Europe
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/28/2017)... ... ... Supplies of the critical medical isotope molybdenum-99 (Mo-99) are secure and reliable ... and Molecular Imaging (SNMMI) 2017 annual meeting in Denver, Colorado in June. Mo-99 ... million nuclear medicine procedures worldwide every year. (1) , Sally Schwarz, President of ...
(Date:6/27/2017)... ... June 27, 2017 , ... Brain State Technologies, a ... campaign on June 15th to fund production of the new B2v2 wearable brainwave ... Kickstarter goal by more than 150% in a little over a week. , ...
(Date:6/27/2017)... ... June 27, 2017 , ... Indiana-based Xylogenics ... yeast production and fermentation process. The efficiencies created by the newest strain ... most notably the ethanol industry wherein individual production plants are planning to invest ...
(Date:6/26/2017)... ... 2017 , ... Third Wave Bioactives, LLC announces the addition of Brett Thompson. ... business development and ensuring quality customer experience. , Brett brings to Third ... technical, marketing and sales roles. “Brett’s background working with customers and eye for market ...
Breaking Biology Technology:
(Date:4/13/2017)... UBM,s Advanced Design and Manufacturing event in ... and evolving technology through its 3D Printing and Smart ... the expo portion of the event and feature a ... on trending topics within 3D printing and smart manufacturing. ... will take place June 13-15, 2017 at the Jacob K. ...
(Date:4/11/2017)... 11, 2017 Research and Markets has announced ... report to their offering. ... global eye tracking market to grow at a CAGR of 30.37% ... Tracking Market 2017-2021, has been prepared based on an in-depth market ... landscape and its growth prospects over the coming years. The report ...
(Date:4/6/2017)... Forecasts by Product Type (EAC), ... End-Use (Transportation & Logistics, Government & Public Sector, Utilities ... Generation Facility, Nuclear Power), Industrial, Retail, Business Organisation (BFSI), ... you looking for a definitive report on the $27.9bn ... ...
Breaking Biology News(10 mins):